UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000006897 |
|---|---|
| Receipt number | R000008152 |
| Scientific Title | Quantitative and functional analyses of proteins in intraocular humor in patients with intraocular angiogenic diseases |
| Date of disclosure of the study information | 2011/12/19 |
| Last modified on | 2011/12/16 18:24:23 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Quantitative and functional analyses of proteins in intraocular humor in patients with intraocular angiogenic diseases
Acronym
Quantitative and functional analyses of proteins in intraocular humor in patients with intraocular angiogenic diseases
Scientific Title
Quantitative and functional analyses of proteins in intraocular humor in patients with intraocular angiogenic diseases
Scientific Title:Acronym
Quantitative and functional analyses of proteins in intraocular humor in patients with intraocular angiogenic diseases
Region
| Japan |
Condition
Condition
diabetic retinopathy, bronchial retinal vein occulusion, age-related macular degenelation, uveitis, macular hole, epiretinal membrene, retinal detachement
Classification by specialty
| Ophthalmology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this research investigates the growth factor which extracts a sample from intraocular fluid(aqueous humor, vitreous body) or blood which undergoes an operation or not. Then we examine a kind and quantity or the property of a growth factor working in the eye. By investigating them, the cause and structure which a new blood vessel, a retinal edema or inflammation, etc. generates were found, and we think that it will be useful for a new cure in the future.
Basic objectives2
Others
Basic objectives -Others
The purpose of this research investigates the growth factor which extracts a sample from intraocular fluid(aqueous humor, vitreous body) or blood which undergoes an operation or not. Then we examine a kind and quantity or the property of a growth factor working in the eye. By investigating them, the cause and structure which a new blood vessel, a retinal edema or inflammation, etc. generates were found, and we think that it will be useful for a new cure in the future.
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Association between clinical findings and protein levels or functions in intraocular humor
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Inclusion criterion is the patient under hospitalization or going to hospital regularly in the Kyoto University hospital with retina diseases, such as diabetes retinopathy, retinal vein occlusion, uveitis, a macular hole, an epiretinal membrane, and retinal detachment.
Key exclusion criteria
We exclude the patients without a disease raised upword, and with the increase in a risk of following on extraction, such as anterior chamber disappearance, and an intraocular pressure fall. Furthermore, the patient to whom cognition and an intelligent function are falling, and the other patients who admit that doctor is unsuitable except.
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Nagahisa Yoshimura |
Organization
Kyouto-univercity
Division name
ophthalmology
Zip code
Address
54 shogoin-kawaharacyo, sakyo-ku, kyoto
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
Kyouto-univercity
Division name
ophthalmology
Zip code
Address
TEL
Homepage URL
tayo2525@kuhp.kyoto-u.ac.jp
Sponsor or person
Institute
kyoto-univercity
Institute
Department
Personal name
Funding Source
Organization
department of ophthalmology & visual science kyoto univercity graduate school of medicine
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2011 | Year | 12 | Month | 19 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2011 | Year | 12 | Month | 16 | Day |
Date of IRB
Anticipated trial start date
| 2011 | Year | 12 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
The purpose of this research investigates the growth factor which extracts a sample from intraocular fluid(aqueous humor, vitreous body) or blood which undergoes an operation or not. Then we examine a kind and quantity or the property of a growth factor working in the eye. By investigating them, the cause and structure which a new blood vessel, a retinal edema or inflammation, etc. generates were found, and we think that it will be useful for a new cure in the future.
Management information
Registered date
| 2011 | Year | 12 | Month | 16 | Day |
Last modified on
| 2011 | Year | 12 | Month | 16 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008152
